119 related articles for article (PubMed ID: 21744351)
21. Hepatic oval (stem) cell expression of endothelial differentiation gene receptors for lysophosphatidic acid in mouse chronic liver injury.
Sautin YY; Jorgensen M; Petersen BE; Saulnier-Blache JS; Crawford JM; Svetlov SI
J Hematother Stem Cell Res; 2002 Aug; 11(4):643-9. PubMed ID: 12201952
[TBL] [Abstract][Full Text] [Related]
22. Lysophospholipid mediators of immunity and neoplasia.
Huang MC; Graeler M; Shankar G; Spencer J; Goetzl EJ
Biochim Biophys Acta; 2002 May; 1582(1-3):161-7. PubMed ID: 12069824
[TBL] [Abstract][Full Text] [Related]
23. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta.
Chen SU; Lee H; Chang DY; Chou CH; Chang CY; Chao KH; Lin CW; Yang YS
Endocrinology; 2008 Nov; 149(11):5888-96. PubMed ID: 18617617
[TBL] [Abstract][Full Text] [Related]
24. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells.
Ren Y; Guo L; Tang X; Apparsundaram S; Kitson C; Deguzman J; Fuentes ME; Coyle L; Majmudar R; Allard J; Truitt T; Hamid R; Chen Y; Qian Y; Budd DC
Microvasc Res; 2013 Jan; 85():59-67. PubMed ID: 23084965
[TBL] [Abstract][Full Text] [Related]
25. Diverse effects of LPA receptors on cell motile activities of cancer cells.
Tsujiuchi T; Hirane M; Dong Y; Fukushima N
J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191
[TBL] [Abstract][Full Text] [Related]
26. Non-Edg family lysophosphatidic acid (LPA) receptors.
Ishii S; Noguchi K; Yanagida K
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):57-65. PubMed ID: 19524700
[TBL] [Abstract][Full Text] [Related]
27. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells.
Goetzl EJ; Dolezalova H; Kong Y; Zeng L
Cancer Res; 1999 Sep; 59(18):4732-7. PubMed ID: 10493533
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ; Kong Y; Mei B
J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
[TBL] [Abstract][Full Text] [Related]
29. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.
Kato K; Yoshikawa K; Tanabe E; Kitayoshi M; Fukui R; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Oct; 33(5):1739-44. PubMed ID: 22678979
[TBL] [Abstract][Full Text] [Related]
30. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
[TBL] [Abstract][Full Text] [Related]
31. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.
Goetzl EJ; Dolezalova H; Kong Y; Hu YL; Jaffe RB; Kalli KR; Conover CA
Cancer Res; 1999 Oct; 59(20):5370-5. PubMed ID: 10537322
[TBL] [Abstract][Full Text] [Related]
32. Current progress in non-Edg family LPA receptor research.
Yanagida K; Kurikawa Y; Shimizu T; Ishii S
Biochim Biophys Acta; 2013 Jan; 1831(1):33-41. PubMed ID: 22902318
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acid is a bioactive mediator in ovarian cancer.
Fang X; Schummer M; Mao M; Yu S; Tabassam FH; Swaby R; Hasegawa Y; Tanyi JL; LaPushin R; Eder A; Jaffe R; Erickson J; Mills GB
Biochim Biophys Acta; 2002 May; 1582(1-3):257-64. PubMed ID: 12069836
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Edg-Like LPA Receptor-Ligand Interactions.
Balogh B; Pazmany T; Matyus P
Curr Pharm Des; 2015; 21(24):3533-47. PubMed ID: 25686617
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
Yamauchi A; Yamamura M; Katase N; Itadani M; Okada N; Kobiki K; Nakamura M; Yamaguchi Y; Kuribayashi F
BMC Cancer; 2017 Mar; 17(1):234. PubMed ID: 28359316
[TBL] [Abstract][Full Text] [Related]
36. Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes.
Zheng Y; Voice JK; Kong Y; Goetzl EJ
FASEB J; 2000 Dec; 14(15):2387-9. PubMed ID: 11024010
[TBL] [Abstract][Full Text] [Related]
37. [Lysophosphatidic acid: a "bioactive" phospholipid].
Saulnier-Blache JS
Med Sci (Paris); 2004; 20(8-9):799-803. PubMed ID: 15361348
[TBL] [Abstract][Full Text] [Related]
38. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.
Hayashi M; Okabe K; Kato K; Okumura M; Fukui R; Fukushima N; Tsujiuchi T
Cancer Lett; 2012 Mar; 316(1):91-6. PubMed ID: 22079467
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
Zeng Y; Kakehi Y; Nouh MA; Tsunemori H; Sugimoto M; Wu XX
Prostate; 2009 Feb; 69(3):283-92. PubMed ID: 19025891
[TBL] [Abstract][Full Text] [Related]
40. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands.
Kostenis E
J Cell Biochem; 2004 Aug; 92(5):923-36. PubMed ID: 15258916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
